Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-03-05

FDA Approved: MUCUS DM — Original Application (HyVee Inc)

View source ↗

Summary

FDA approved HyVee Inc's MUCUS DM as an original-application generic product containing dextromethorphan hydrobromide and guaifenesin for temporary relief of co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MUCUS DM (Dextromethorphan hydrobromide and guaifenesin)

Snippet

ORIG AP for MUCUS DM (DEXTROMETHORPHAN HBR, GUAIFENESIN)